Log in or Sign up for Free to view tailored content for your specialty!
Psoriatic Arthritis News
FDA approves Taltz for psoriatic arthritis in adults
The FDA has approved ixekizumab injections of 80 mg/mL for the treatment of adults with active psoriatic arthritis, according to a press release from its manufacturer.
Adverse event rates greater in first year of psoriatic arthritis treatment with systemic therapies
Overall adverse event rates were greater in the first year of treatment compared with subsequent years for all drugs used to treat patients with psoriatic arthritis.
Log in or Sign up for Free to view tailored content for your specialty!
Prevalence of arthritis in US 'substantially underestimated'
Arthritis prevalence in the United States has been “substantially underestimated” by as much as 68%, according to research published in Arthritis & Rheumatology.
PsA scoring systems showed moderate sensitivity, high specificity in detecting change
The quantifying of radiographic axial psoriatic arthritis through currently available scoring systems has moderate sensitivity but high specificity for identifying true change, according to results.
Psoriasis, inflammatory diseases increase risk for cirrhosis, fatty liver
Patients with inflammatory disorders, especially psoriasis and psoriatic arthritis, had an elevated risk for severe liver disease such as nonalcoholic fatty liver disease and cirrhosis, according to a recently published study.
Janssen Biotech receives FDA approval for Simponi Aria for the treatment of active PsA, AS
Janssen announced it has received FDA approvals for Simponi Aria for the treatment of adults with psoriatic arthritis or active ankylosing spondylitis, according to a company press release.
Ace the Case: A 29-year-old Woman With Psoriasis Vulgaris
A 29-year-old woman presents to the clinic to establish care for her psoriasis vulgaris. She states her psoriasis began when she was 22 years old and she has been treated with topical glucocorticoids in the past. During the past 2 years, she has not used any topical medications because her psoriasis has not been bothersome. However, lately her psoriasis plaques have been pruritic and she has several new lesions on her legs that make her embarrassed to wear shorts.
Disability prevention program lessened work loss due to rheumatic, musculoskeletal conditions
A non-rigorous, work disability prevention program appeared to be effective in avoiding work loss in patients with chronic rheumatic and musculoskeletal conditions, according to findings.
Secukinumab yielded improvements for PsA through 2 years
In patients with active psoriatic arthritis, secukinumab yielded continued improvements in signs, symptoms and multiple clinical domains through 2 years of therapy, according to data from the FUTURE 2 study.
Five important news items about psoriatic arthritis
Healio.com Rheumatology features five news items about psoriatic arthritis. More coverage can be found by clicking here.